stars 1 stars 2 stars 3

Founded in 2004, RiboBio is a leading biotechnology company focusing on RNA-based products and services at state-of-the-art facilities. RiboBio was ranked the No. 1 company by revenue offering RNA-based products and services in China by the 2017 Frost & Sullivan Report. RiboBio is dedicated to providing diversified and high-quality reagents, such as siRNA, miRNA mimics and inhibitors, LncRNA probes, and smart silencing kits used for RNA-related research. With 15+ years of experience in synthesizing and manufacturing oligonucleotides of various configurations and chemistry, we have produced and commercialized over 1,000,000 oligonucleotides. RiboBio provides unique “one-stop” RNA-based outsourcing services to meet and exceed our customer’s product needs, from drug discovery and development, to manufacturing, by offering CRO services and CDMO services, including manufacturing services of both GMP and non-GMP oligo-based APIs. Learn more about our CDMO and CRO capabilities here: https://cdmocmo.ribobio.com/en/ #RiboBio

RiboBio Questions

The RiboBio annual revenue was $23.2 million in 2026.

4 people are employed at RiboBio.

RiboBio is based in Guangzhou, Guangdong.

The NAICS codes for RiboBio are [54171, 541, 5417, 541713, 54].

The SIC codes for RiboBio are [873, 87].

Top RiboBio Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users